Table 1. The Patient’s Clinical Findings and Laboratory Data on an Initial Medical Examination.

From: A Novel Missense MEN1 Mutation in a Sporadic Case of Multiple Endocrine Neoplasia Type 1 Complicated with Papillary Thyroid Carcinoma

This case Normal range
SBP/DBP (mmHg) 106/68 130/80
BMI (kg/m2) 19.3 18.5-25
FPG (mg/dL) 85 73-109
ALP (IU/L) 695 106-322
Na (mmol/L) 139 138-145
K (mmol/L) 4.4 3.6-4.8
Ca (mg/dL) 12.5 8.8-10.1
P (mg/dL) 2.2 2.7-4.6
Mg (mg/dL) 2.3 1.7-2.5
FECa (%) 0.67 <1.0
Intact-PTH (pg/mL) 496 10-65
ACTH (pg/mL) 52.1 7.2-63.3
F (μg/dL) 12.1 6.24-18.0
TSH (μU/mL) 1.17 0.45-3.33
FT3 (pg/mL) 2.37 2.11-3.51
FT4 (ng/dL) 1.09 0.84-1.44
GH (ng/mL) 0.7 <2.1
IGF-1 (ng/mL) 188 133-312
PRL (ng/mL) 11.3 3.12-15.39
LH (mIU/mL) 7.6 0.5-68.7
FSH (mIU/mL) 7.3 1.5-20.6
C-peptide (ng/mL) 1.51 1.1-3.3
Insulin (μU/mL) 7.9 <16
Gastrin (pg/mL) 95 <200
Glucagon (pg/mL) 208 70-174
Thyroglobulin (ng/mL) 106 <33.7
25-hydroxyvitamin D (ng/mL) 9.9 >20
Table 2. Reported Substitutions of Arginine at Codon 98 of the MEN1 Protein and Their Predictions of Functional Effects.

From: A Novel Missense MEN1 Mutation in a Sporadic Case of Multiple Endocrine Neoplasia Type 1 Complicated with Papillary Thyroid Carcinoma

Nucleotide change (amino acid change) Source PolyPhen2 (Score/prediction) PROVEAN (Score/prediction)
c.293G>C (p.R98P) This case 0.995/probably damaging -4.805/deleterious
c.293G>A (p.R98Q) ClinVar 0.743/possibly damaging -2.341/neutral
c.293G>T (p.R98L) Article (1) 0.966/probably damaging -4.889/deleterious
PAGE TOP